KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
16.65
+1.04 (6.66%)
Mar 4, 2026, 2:32 PM EST - Market open

KalVista Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY FY FY FY FY
Period Ending
Mar '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21
842685483291313610
Market Cap Growth
74.50%41.98%65.58%-6.74%-48.75%213.22%
Enterprise Value
736.02470.91279.54150.34154.52366.81
Last Close Price
16.6513.7711.358.5312.7324.97
PE Ratio
--3.73-3.30-2.56-3.79-10.32
PS Ratio
553.32-----
PB Ratio
19.267.182.341.811.692.37
P/TBV Ratio
-7.172.021.481.681.85
P/FCF Ratio
--4.47-5.41-3.81-3.95-20.16
P/OCF Ratio
--4.48-5.41-3.87-4.00-20.21
EV/Sales Ratio
516.15-----
EV/EBITDA Ratio
--2.52-2.00-1.36-1.61-6.39
EV/EBIT Ratio
--2.50-1.99-1.36-1.60-6.33
EV/FCF Ratio
--3.07-3.13-1.97-1.95-12.12
Debt / Equity Ratio
8.800.070.040.050.040.02
Debt / EBITDA Ratio
--0.03-0.05-0.07-0.08-0.10
Debt / FCF Ratio
--0.04-0.08-0.11-0.10-0.19
Net Debt / Equity Ratio
-9.39-2.25-0.98-0.88-0.85-0.94
Net Debt / EBITDA Ratio
-1.151.451.281.654.24
Net Debt / FCF Ratio
-1.402.281.852.008.03
Quick Ratio
7.024.929.6011.0415.5826.53
Current Ratio
7.225.359.9011.4616.7327.04
Return on Equity (ROE)
--121.50%-68.90%-53.69%-37.23%-27.13%
Return on Assets (ROA)
--78.79%-67.10%-57.29%-40.60%-31.78%
Return on Invested Capital (ROIC)
--26219.94%-1201.41%-472.18%-468.40%-363.66%
Return on Capital Employed (ROCE)
--89.91%-73.77%-61.51%-42.51%-33.38%
Earnings Yield
-25.74%-26.80%-30.31%-39.04%-26.39%-9.69%
FCF Yield
-21.28%-22.38%-18.50%-26.23%-25.30%-4.96%
Buyback Yield / Dilution
--9.00%-31.23%-19.94%-0.51%-34.78%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q